BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/8/2024 8:08:55 AM | Browse: 67 | Download: 9
Category |
Ophthalmology |
Manuscript Type |
Editorial |
Article Title |
Potential prospects of Chinese medicine application in diabetic retinopathy
|
Manuscript Source |
Invited Manuscript |
All Author List |
Yi-Mai Zhou, Yuan-Hao Cao, Jing Guo and Lu-Sha Cen |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
82104862 |
Scientific Research Project Foundation of Zhejiang Chinese Medical University |
2023FSYYZZ01 and 2023RCZXZK49 |
|
Corresponding Author |
Lu-Sha Cen, PhD, Attending Doctor, Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), No. 54 Youdian Road, Hangzhou 310006, Zhejiang Province, China. cenlusa2@sina.com |
Key Words |
Diabetic retinopathy; Traditional Chinese medicine; Genipin; Topical application; Advanced glycation end products |
Core Tip |
In this study, in vitro experiments showed that genipin can reverse high glucose-induced damage in cell proliferation and apoptosis, while reducing energy metabolism, oxidative stress, and inflammatory injury induced by high glucose. The in vitro results showed that intravitreal injection with genipin reduced the expression of CHGA, UCP2, and glucose transporter 1 (GLUT1), and the CHGA/UCP2/GLUT1 signalling pathway may play an important role in this process. This study innovatively treated streptozotocin-induced mice with an intraocular injection of genipin, and concluded that genipin ameliorates diabetic retinopathy by downregulating advanced glycation end products, thereby protecting human retinal microvascular endothelial cells. |
Citation |
<p>Zhou YM, Cao YH, Guo J, Cen LS. Potential prospects of Chinese medicine application in diabetic retinopathy. <i>World J Diabetes</i> 2024; 15(10): 2010-2014</p> |
|
Received |
|
2024-04-30 12:30 |
|
Peer-Review Started |
|
2024-04-30 12:30 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-05-22 05:15 |
|
Revised |
|
2024-06-03 09:12 |
|
Second Decision |
|
2024-07-08 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-07-08 08:08 |
|
Articles in Press |
|
2024-07-08 08:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-07-16 01:16 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345